Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pleural Malignant Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05429866
What this trial is testing

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Who this might be right for
Breast CancerMelanomaNon Small Cell Lung Cancer+10 more
Jules Bordet Institute 441
Testing effectiveness (Phase 2)Study completedNCT05455424
What this trial is testing

Niraparib Efficacy in Patient With Unresectable Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University Hospital Southampton NHS Foundation Trust 88
Testing effectiveness (Phase 2)Study completedNCT05380713
What this trial is testing

......SMARTEST Trial......

Who this might be right for
Mesothelioma, Malignant
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Study completedNCT00039182
What this trial is testing

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 55
Not applicableStudy completedNCT00720954
What this trial is testing

Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy

Who this might be right for
Pleural EffusionPleural Diseases
Eskisehir Osmangazi University 124
Testing effectiveness (Phase 2)Study completedNCT00003723
What this trial is testing

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)UnknownNCT01655888
What this trial is testing

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese 29
Testing effectiveness (Phase 2)Ended earlyNCT03075527
What this trial is testing

Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Dana-Farber Cancer Institute 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT06318286
What this trial is testing

Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Hyogo Medical University 25
Early research (Phase 1)Study completedNCT00535951
What this trial is testing

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

Who this might be right for
Carcinoma, Non-Small-Cell LungMesothelioma
Novartis Pharmaceuticals 18
Not applicableStudy completedNCT02300883
What this trial is testing

Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients

Who this might be right for
Malignant Mesothelioma
Armando Santoro, MD 100
Not applicableStudy completedNCT02603315
What this trial is testing

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)

Who this might be right for
Malignant Pleural Mesotheliomas
Ain Shams University 50
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Testing effectiveness (Phase 2)UnknownNCT05598268
What this trial is testing

T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid TumorLung CancerLiver Cancer+2 more
ImmVira Pharma Co. Ltd 74
Testing effectiveness (Phase 2)Study completedNCT03654833
What this trial is testing

Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University of Leicester 186
Testing effectiveness (Phase 2)Study completedNCT01358084
What this trial is testing

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM

Who this might be right for
Advanced Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 137
Not applicableStudy completedNCT01776385
What this trial is testing

The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma

Who this might be right for
Pleural NeoplasmsMesotheliomaPneumothorax+3 more
Centre Hospitalier Universitaire de Nice 9
Large-scale testing (Phase 3)Study completedNCT02899299
What this trial is testing

Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients

Who this might be right for
Mesothelioma
Bristol-Myers Squibb 605
Not applicableUnknownNCT03210298
What this trial is testing

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Who this might be right for
Peritoneum CancerPeritoneum NeoplasmPleural Cancer+12 more
Sabine Rhode 1,000
Early research (Phase 1)Ended earlyNCT06299163
What this trial is testing

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more
Numab Therapeutics AG 11
Next Page